← back to search

Zhen‐Yu He

Sun Yat-sen University · CN
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Breast Implant and Reconstruction, and Head and Neck Cancer Studies.
h-index
34
citations
4,893
works
215
NIH funding
primary concept
Medicine
email

Recent publications

Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.
2026cited by 0position: contributordoi
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
The Lancet 2024cited by 162position: middledoi
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
2024cited by 2position: contributordoi
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Breast Cancer Targets and Therapy 2024cited by 1position: middledoi
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.
2022cited by 2position: contributordoi
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
Journal of Experimental & Clinical Cancer Research 2021cited by 74position: middledoi
Fuzzy measure with regularization for gene selection and cancer prediction
International Journal of Machine Learning and Cybernetics 2021cited by 13position: middledoi
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
2021cited by 10position: contributordoi
Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
2021cited by 6position: contributordoi
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
JAMA 2020cited by 223position: middledoi
The IAA- and ABA-responsive transcription factor CgMYB58 upregulates lignin biosynthesis and triggers juice sac granulation in pummelo
Horticulture Research 2020cited by 108position: middledoi
The Value of Prognostic Nutritional Index (PNI) in Predicting Survival and Guiding Radiotherapy of Patients With T1-2N1 Breast Cancer
Frontiers in Oncology 2020cited by 83position: middledoi
Prognostic validation and therapeutic decision-making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy.
2020cited by 12position: contributordoi
21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
Frontiers in Oncology 2019cited by 360position: lastdoi
Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma.
2019cited by 12position: contributordoi
The 1-year mortality after radiotherapy for nasopharyngeal carcinoma: a population-based analysis.
2019cited by 1position: contributordoi
Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer
Frontiers in Oncology 2018cited by 91position: lastdoi
Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3
Cancer Management and Research 2018cited by 77position: middledoi
<scp>ANP</scp>32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1
Molecular Oncology 2018cited by 76position: middledoi
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer
Breast Cancer Research 2017cited by 131position: lastdoi
Sites of metastasis and overall survival in esophageal cancer: a population-based study
Cancer Management and Research 2017cited by 106position: middledoi
The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
Journal of Cancer 2017cited by 83position: middledoi
The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis
Tumor Biology 2017cited by 75position: lastdoi
Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis
Expert Review of Gastroenterology & Hepatology 2017cited by 73position: middledoi
Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: A population-based analysis
Oral Oncology 2017cited by 71position: middledoi
Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis
Journal of Cancer Research and Clinical Oncology 2016cited by 99position: lastdoi
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT
Translational Oncology 2016cited by 63position: firstdoi
Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer
The Breast 2013cited by 118position: middledoi
Quality of Life and Radiotherapy Complications of Chinese Nasopharyngeal Carcinoma Patients at Different 3DCRT Stages
Asian Pacific Journal of Cancer Prevention 2012cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wen W. Zhang · Sun Yat-sen University8 papers (2017–2021)Feng-Yan Li · Sun Yat-sen University7 papers (2013–2018)San‐Gang Wu · Sun Yat-sen University Cancer Center7 papers (2013–2018)Jiayuan Sun · National Yang Ming Chiao Tung University7 papers (2013–2019)Huan‐Xin Lin · Sun Yat-sen University5 papers (2013–2021)San‐Gang Wu · Hebei Medical University4 papers (2016–2019)Ling Guo · Hebei Medical University4 papers (2013–2020)Chuyong Lin · Sun Yat-sen University3 papers (2017–2021)Liping Ye · Sun Yat-sen University3 papers (2017–2021)Xin Hua · Beijing YouAn Hospital2 papers (2020–2021)Jia-Yuan Sun · Sun Yat-sen University2 papers (2017–2017)Qin Lin · Xiamen University2 papers (2017–2018)Xianqiu Wu · Nanfang Hospital2 papers (2018–2021) · 2 papers (2024–2026)Yongxiong Chen · Xiamen University2 papers (2017–2019)Libing Song · Sun Yat-sen University2 papers (2017–2018)Liying Tang · Nanchang University2 papers (2017–2017)Zhi‐Qing Long · Sun Yat-sen University2 papers (2020–2021)Xueting Chen · Shanghai Medical College of Fudan University2 papers (2017–2017)Qin Lin · Zhongshan Hospital of Xiamen University2 papers (2013–2017)